Health Effects Monitoring Team

The LRI Health Effects Monitoring Team (HEMT) oversees LRI programme development and progress in funded research on chemical carcinogenicity, chemical allergy, neurodevelopmental disorders in children, the development of alternative approaches in mammalian toxicity testing, and new areas like epigenetics and human health effects of nanomaterials.

Current Membership 

• Core Team Members
  
  • Gerard Swaen - Chairman (Dow)
  • Hans-Juergen Ahr (Bayer HealthCare)
  • Peter Boogaard (Shell Chemicals)
    
• Extended Team Members
  • Peter Carthew (Unilever)
  • Emanuela Corsini (University of Milan)
  • Alan Poole (Dow)

Secretariat

• Christa Hennes - Scientific Officer
• Anita Jennings - Administrative Support